The North America Hospital-Acquired Infection Diagnostics Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The healthcare establishment bears a duty to HAI prevention. Sterilization and disinfection guidelines should be followed by hospitals and healthcare personnel. Taking precautions to avoid HAIs can reduce the chance of catching them by significant percentage. Although, because of the nature of healthcare facilities, eliminating all nosocomial diseases is unachievable.
The risk of hospital-acquired illnesses is determined by the facility's infection control policies, the patient's immunological condition, and the community's presence of different pathogens. Immuno suppression, advanced age, duration of hospital stays, various underlying comorbidities, frequent trips to healthcare institutions, mechanical ventilator assistance, recent invasive surgeries, indwelling devices, and all of the things put person at risk for HAI if person stay in an intensive care unit (ICU). One of the greatest risk factors for developing antimicrobial resistance to various medicines is receiving intravenous antibiotics during the last 90 days. Other patients, healthcare workers, or the hospital environment are among the potential spreaders of the diseases.
A great progress has been made in preventing the spread of some healthcare-associated illness types with the sincere efforts of regional government and healthcare bodies, as per the Centers for Disease Control and Prevention (CDC) 2021, but still it has so much work to complete. On any particular day, one out of each and every 31 hospital patients in the United States has minimum one healthcare-related infection. North America, particularly the United States and Canada, has achieved great progress toward the shared objective of eliminating HAIs, and as an outcome, healthcare in this region is safer than it was even several years ago. The rise in chronic conditions like cardiovascular disease and others necessitates longer hospital stays, resulting in an increase in hospital-acquired infection incidents. As per American Health Association figures from 2020, multiple million hospital admissions occurred in 2019. It is vital to build on this accomplishment and continue to work on the removal of hospital-acquired infections.
The US market dominated the North America Hospital-Acquired Infection Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,422.1 million by 2028. The Canada market is estimated to grow at a CAGR of 9.5% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.5% during (2022 - 2028).
Based on Product, the market is segmented into Reagents & Consumables and Instrument. Based on Infection Type, the market is segmented into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and Others. Based on Application, the market is segmented into Drug-Resistance Testing and Disease Testing. Based on Test Type, the market is segmented into Molecular Diagnostics, Immunoassay, and Urinalysis. Based on End User, the market is segmented into Hospital, Standalone Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Hospital-Acquired Infection Diagnostics Market is Estimated to reach $5.6 Billion by 2028, at a CAGR of 7.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG (Bayer Schering Pharma AG), Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Ecolab, Inc., Pfizer, Inc., Steris PLC, Johnson & Johnson, Abbott Laboratories, and Merck Group.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Reagents & Consumables
- Instrument
By Infection Type
- Urinary Tract Infections (UTI)
- Hospital Acquired Pneumonia
- Bloodstream Infections
- Surgical Site Infections
- Gastrointestinal Infections
- Others
By Application
- Drug-Resistance Testing
- Disease Testing
By Test Type
- Molecular Diagnostics
- Immunoassay
- Urinalysis
By End User
- Hospital
- Standalone Laboratories
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG (Bayer Schering Pharma AG)
- Danaher Corporation
- Becton, Dickinson and Company
- Hologic, Inc.
- Ecolab, Inc.
- Pfizer, Inc.
- Steris PLC
- Johnson & Johnson
- Abbott Laboratories
- Merck Group
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 North America Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 North America Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 North America Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 North America Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 North America Hospital-Acquired Infection Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Hospital-Acquired Infection Diagnostics Market by Product
4.1 North America Reagents & Consumables Market by Country
4.2 North America Instrument Market by Country
Chapter 5. North America Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 North America Urinary Tract Infections (UTI) Market by Country
5.2 North America Hospital Acquired Pneumonia Market by Country
5.3 North America Bloodstream Infections Market by Country
5.4 North America Surgical Site Infections Market by Country
5.5 North America Gastrointestinal Infections Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Hospital-Acquired Infection Diagnostics Market by Application
6.1 North America Drug-Resistance Testing Market by Country
6.2 North America Disease Testing Market by Country
Chapter 7. North America Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 North America Molecular Diagnostics Market by Country
7.2 North America Immunoassay Market by Country
7.3 North America Urinalysis Market by Country
Chapter 8. North America Hospital-Acquired Infection Diagnostics Market by End User
8.1 North America Hospital Market by Country
8.2 North America Standalone Laboratories Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Hospital-Acquired Infection Diagnostics Market by Country
9.1 US Hospital-Acquired Infection Diagnostics Market
9.1.1 US Hospital-Acquired Infection Diagnostics Market by Product
9.1.2 US Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.3 US Hospital-Acquired Infection Diagnostics Market by Application
9.1.4 US Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.5 US Hospital-Acquired Infection Diagnostics Market by End User
9.2 Canada Hospital-Acquired Infection Diagnostics Market
9.2.1 Canada Hospital-Acquired Infection Diagnostics Market by Product
9.2.2 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.3 Canada Hospital-Acquired Infection Diagnostics Market by Application
9.2.4 Canada Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.5 Canada Hospital-Acquired Infection Diagnostics Market by End User
9.3 Mexico Hospital-Acquired Infection Diagnostics Market
9.3.1 Mexico Hospital-Acquired Infection Diagnostics Market by Product
9.3.2 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.3 Mexico Hospital-Acquired Infection Diagnostics Market by Application
9.3.4 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.5 Mexico Hospital-Acquired Infection Diagnostics Market by End User
9.4 Rest of North America Hospital-Acquired Infection Diagnostics Market
9.4.1 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product
9.4.2 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.3 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application
9.4.4 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.5 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User
Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements
TABLE 1 North America Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 North America Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hospital-Acquired Infection Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Hospital-Acquired Infection Diagnostics Market
TABLE 5 Acquisition and Mergers– Hospital-Acquired Infection Diagnostics Market
TABLE 6 Approvals and Trials - Hospital-Acquired Infection Diagnostics Market
TABLE 7 North America Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 8 North America Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 9 North America Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Instrument Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Instrument Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 14 North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 15 North America Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 28 North America Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 29 North America Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 34 North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 35 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 42 North America Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 43 North America Hospital Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Hospital Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 51 US Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 52 US Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 53 US Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 54 US Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 55 US Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 56 US Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 57 US Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 58 US Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 59 US Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 60 US Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 61 US Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 62 US Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 63 Canada Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 Canada Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 Canada Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 66 Canada Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 67 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 68 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 69 Canada Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 70 Canada Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 71 Canada Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 72 Canada Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 73 Canada Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 74 Canada Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 75 Mexico Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 76 Mexico Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 77 Mexico Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 78 Mexico Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 79 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 80 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 81 Mexico Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 82 Mexico Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 83 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 84 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 85 Mexico Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 86 Mexico Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 87 Rest of North America Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 88 Rest of North America Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 89 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 90 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 91 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 92 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 93 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 94 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 95 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 98 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 99 Key Information – Bayer AG
TABLE 100 Key Information – Danaher Corporation
TABLE 101 Key information – Becton, Dickinson and Company
TABLE 102 Key information – Hologic, Inc.
TABLE 103 Key Information – Ecolab, Inc.
TABLE 104 Key Information – Pfizer, Inc.
TABLE 105 key information – Steris PLC
TABLE 106 Key information – Johnson & Johnson
TABLE 107 Key Information – Abbott Laboratories
TABLE 108 key Information – Merck GrouP
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent Strategies and Developments: Becton, Dickinson and Company
FIG 5 Recent Strategies and Developments: Hologic, Inc.
FIG 6 Recent Strategies and Developments: Ecolab, Inc.
FIG 7 Recent Strategies and Developments: Pfizer, Inc.
FIG 8 Recent Strategies and Developments: Abbott Laboratories